Home

As the world deals with the unrelenting daily spread of the novel coronavirus ESWI wants to look further down the road.

Could countries face two epidemics at the same time next fall, flu and the coronavirus? It is possible that a new surge in coronavirus cases could coincide with the next flu season, causing - potentially - an even more difficult crisis than the one the world is facing now?

We know that the only thing predictable about flu is, that it’s unpredictable.

When flu season comes, there is a possibility that the world will be dealing with two respiratory viruses at the same time – flu and COVID-19. This could be a double challenge for health care systems worldwide.

Are countries ready for how the coronavirus may impact the next flu season?

How can we safeguard flu vaccination (as one of the greatest tools we have as we go through the fall-winter season) and thereby minimize the impact of
flu to the other respiratory disease we confront?

How can antivirals be used in the upcoming flu epidemic?

Coronavirus,
Flu and RSV
colliding in the fall:

Conclusions and recommendations

Conclusions and Recommendations

Programme

Webinar 1:
Thursday 11 June 2020 | 16:00 - 18:00 (CET)
completed

INFLUENZA AND RSV IN A COVID-19 WORLD

Session 1
Influenza, RSV and COVID-19: similarities and differences
Arnold Monto , University of Michigan , USA
Image
Arnold Moto
Session 2
Epidemiology: what if COVID-19 strikes in the flu season?
Colin Russel , University of Amsterdam , The Netherlands
Image
colinrussell
Session 3
Challenges in serology for COVID-19
Linfa Wang , Duke-NUS Medical School , Singapore
Image
Linfa
Session 4
Diagnoses for influenza, RSV and COVID-19 and consequences
Marco Goeijenbier , Erasmus MC , The Netherlands
Image
Marco Goeijenbier

Conclusion and recommendations of webinar 1:
INFLUENZA AND RSV IN A COVID-19 WORLD

by Professor Ab Osterhaus

This session is now completed.


Webinar 2:
Thursday 18 June 2020 | 16:00 - 18:00 (CET)
completed

CLINICAL MANIFESTATIONS OF COVID-19, INFLUENZA AND RSV

Session 1
Clinical signs and symptoms: overlap and differences
Barbara Rath , Vienna Vaccine Safety Initiative , Germany
Image
Rath
Session 2
Risk groups: overlap and differences
Daniel Feikin , World Health Organisation , Switzerland
Image
Daniel Feikin
Session 3
Clinical guidance and symptomatic treatment
Peter Openshaw , Imperial College London , United Kingdom
Image
Peter
Session 4
Co-infections: possible scenario’s
Bruno Lina , Université de Lyon , France
Image
bruno lina

Conclusion and recommendations of webinar 2:
CLINICAL MANIFESTATIONS OF COVID-19, INFLUENZA AND RSV

by Professor Ab Osterhaus

This session is now completed.


Webinar 3:
Tuesday 23 June 2020 | 16:00 - 18:00 (CET)
completed

INTERVENTION STRATEGIES FOR COVID-19, INFLUENZA AND RSV

Session 1
Current strategies
Ab Osterhaus , RIZ, Hannover , Germany
Image
Ab Osterhaus
Session 2
Testing and testing consequences
Chantal Reusken , RIVM , The Netherlands
Image
C Reusken
Session 3
Influenza vaccination during COVID-19
Florian Krammer , Icahn School of Medicine , USA
Image
Florian Krammer
Session 4
Antivirals & Biological Response Modifiers
Mike Ison , Northwestern University , USA
Image
Mike Ison

Conclusion and recommendations of webinar 3:
INTERVENTION STRATEGIES FOR COVID-19, INFLUENZA AND RSV

by Professor Ab Osterhaus

This session is now completed.


Webinar 4:
Thursday 2 July 2020 | 16:00 - 18:00 (CET)
completed

CORNERSTONES OF PANDEMIC PREPAREDNESS AND URGENT ACTIONS

Session 1
Vaccination
Ab Osterhaus , RIZ, Hannover , Germany
Jonathan Anderson , Seqirus , Australia
Image
Ab Osterhaus
Image
Anderson
Session 2
Antivirals
Frederick Hayden , University of Virginia , USA
Image
Fred
Session 3
Non-medical interventions
Angeliki Melidou , ECDC , Sweden
Image
new melidou
Session 4
Cross-sector collaboration and communication
Sylvie Briand , World Health Organisation , Switzerland
Image
Sylvie Briand

Conclusion and recommendations of webinar 4:
CORNERSTONES OF PANDEMIC PREPAREDNESS AND URGENT ACTIONS

by Professor Ab Osterhaus

This session is now completed.

Contact

Annick Mannaerts
Programme Director
annick.mannaerts@eswi.org

ESWI’s partner organisations
Image
epha
Image
elf
Image
eaaci
Image
ers
Image
National Influenza Vaccine Summit
Image
ESPID
Image
EUGMS
Image
FEND
Image
ISTM
Image
IDFE
Image
WHO europe
Image
EMA
Image
euregha
Image
pgeu
Image
wonca
Image
eap
Image
apaci
Image
age
Image
efnnma
Image
vaccines europe
Image
escmid
Image
ehn